11 – 20 of 530
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Large differencies in age-specific survival in multiple myeloma in the nordic countries
- Contribution to journal › Debate/Note/Editorial
-
Mark
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
- Contribution to journal › Debate/Note/Editorial
-
Mark
Critical survival periods in prostate cancer in Sweden explored by conditional survival analysis
- Contribution to journal › Article
-
Mark
Survival in Thyroid Cancer in Sweden From 1999 To 2018
- Contribution to journal › Article
- 2023
-
Mark
Personal comorbidities and their subsequent risks for liver, gallbladder and bile duct cancers
- Contribution to journal › Article
-
Mark
Autoimmune diseases as comorbidities for liver, gallbladder, and biliary duct cancers in Sweden
- Contribution to journal › Article
-
Mark
Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?
- Contribution to journal › Article
-
Mark
Population-Attributable Fractions of Personal Comorbidities for Liver, Gallbladder, and Bile Duct Cancers
- Contribution to journal › Article
-
Mark
Re: Mark N. Brook, Holly Ní Raghallaigh, Koveela Govindasami, et al. Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study. Eur Urol 2023;83:257-66
- Contribution to journal › Letter
-
Mark
Are population level familial risks and germline genetics meeting each other?
- Contribution to journal › Scientific review
